Pfizer Q3 Revenue Beats Estimates; Company Raises Guidance
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…
Story updates
11:54:43 AM UTC
SquawkNews
Pfizer alza stima ricavi 2026 a 62-64 miliardi di dollari Pfizer alza la guidance sui ricavi 202
12:19:50 PM UTC
SquawkNews
Pfizer raises its full-year 2026 revenue guidance by $1.5 billion at the midpoint to between $62 billion and $64.0 billion following strong third-quarter operational performance. The drugmaker also boosted its adjusted diluted EPS outlook to $2.95 to $3.05. Strong momentum in newly launched and acq…
12:20:55 PM UTC
SquawkNews
By Mackenzie TatananniPfizer raised its full-year outlook on the back of a stronger-than-expected quarter, the latest sign that the drugmaker is finding life beyond the pandemic.Pfizer on Tuesday reported third-quarter revenue of $16.6 billion, roughly flat year over year. Still, the figure handily…
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…